Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SpineSmith hires new vice-president of R&D

This article was originally published in Clinica

Executive Summary

In a bid to strengthen its position in adult stem cell technologies, SpineSmith Partners has appointed Brian Burkinshaw vice-president of R&D. Mr Burkinshaw has over 30 years' experience, both with traditional orthopaedic companies and emerging biologic firms, which SpineSmith believes will help it develop regenerative medicine products. He has previously worked for Spinal Restoration, LDR Spine and Zimmer, as well as venture capital firm Path4 Ventures. SpineSmith (Austin, Texas), along with its subsidiary Celling Technologies, plans to launch two new regenerative products "in the coming months". SpineSmith develops implants and biologics for surgical fixation, correction and regeneration of the spine, while Celling is focused on autologous adult stem cell therapies.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT095065

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel